Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D-Targeted CAR T-Cell Therapy for R/R MM - Ph1 Study Results"

69 views
December 15, 2023
Comments 0
Login to view comments. Click here to Login